Gritstone Bio Inc has a consensus price target of $4.2 based on the ratings of 5 analysts. The high is $7 issued by Piper Sandler on September 28, 2023. The low is $2 issued by Goldman Sachs on August 22, 2022. The 3 most-recent analyst ratings were released by JMP Securities, B. Riley Securities, and HC Wainwright & Co. on June 14, 2024, May 24, 2024, and May 13, 2024, respectively. With an average price target of $4 between JMP Securities, B. Riley Securities, and HC Wainwright & Co., there's an implied 495.86% upside for Gritstone Bio Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/14/2024 | Buy Now | 644.82% | JMP Securities | Roy Buchanan | $5 → $5 | Reiterates | Market Outperform → Market Outperform | Get Alert |
05/24/2024 | Buy Now | 346.89% | B. Riley Securities | Mayank Mamtani | $6 → $3 | Reiterates | Buy → Buy | Get Alert |
05/13/2024 | Buy Now | 495.86% | HC Wainwright & Co. | Sean Lee | $7 → $4 | Maintains | Buy | Get Alert |
04/02/2024 | Buy Now | 644.82% | JMP Securities | Roy Buchanan | $4 → $5 | Maintains | Market Outperform | Get Alert |
03/06/2024 | Buy Now | 942.75% | HC Wainwright & Co. | Sean Lee | → $7 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | Buy Now | 495.86% | JMP Securities | Roy Buchanan | → $4 | Initiates | → Market Outperform | Get Alert |
12/07/2023 | Buy Now | 793.79% | B. Riley Securities | Mayank Mamtani | $8 → $6 | Maintains | Buy | Get Alert |
09/28/2023 | Buy Now | 942.75% | Piper Sandler | Edward Tenthoff | $6 → $7 | Maintains | Overweight | Get Alert |
08/10/2023 | Buy Now | 942.75% | HC Wainwright & Co. | Sean Lee | → $7 | Reiterates | Buy → Buy | Get Alert |
05/15/2023 | Buy Now | 942.75% | HC Wainwright & Co. | Sean Lee | → $7 | Reiterates | Buy → Buy | Get Alert |
03/28/2023 | Buy Now | 1091.72% | B. Riley Securities | Mayank Mamtani | → $8 | Initiates | → Buy | Get Alert |
03/14/2023 | Buy Now | 942.75% | HC Wainwright & Co. | Sean Lee | → $7 | Reiterates | → Buy | Get Alert |
02/15/2023 | Buy Now | 942.75% | HC Wainwright & Co. | Sean Lee | → $7 | Maintains | Buy | Get Alert |
11/07/2022 | Buy Now | 942.75% | HC Wainwright & Co. | Sean Lee | $12 → $7 | Maintains | Buy | Get Alert |
10/31/2022 | Buy Now | 793.79% | Piper Sandler | Edward Tenthoff | → $6 | Initiates | → Overweight | Get Alert |
08/22/2022 | Buy Now | 197.93% | Goldman Sachs | Corinne Jenkins | → $2 | Downgrade | Neutral → Sell | Get Alert |
05/09/2022 | Buy Now | 1687.58% | HC Wainwright & Co. | Sean Lee | $15 → $12 | Maintains | Buy | Get Alert |
03/14/2022 | Buy Now | 2134.47% | HC Wainwright & Co. | Sean Lee | $24 → $15 | Maintains | Buy | Get Alert |
The latest price target for Gritstone Bio (NASDAQ:GRTS) was reported by JMP Securities on June 14, 2024. The analyst firm set a price target for $5.00 expecting GRTS to rise to within 12 months (a possible 644.82% upside). 9 analyst firms have reported ratings in the last year.
The latest analyst rating for Gritstone Bio (NASDAQ:GRTS) was provided by JMP Securities, and Gritstone Bio reiterated their market outperform rating.
There is no last upgrade for Gritstone Bio
The last downgrade for Gritstone Bio Inc happened on August 22, 2022 when Goldman Sachs changed their price target from N/A to $2 for Gritstone Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gritstone Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gritstone Bio was filed on June 14, 2024 so you should expect the next rating to be made available sometime around June 14, 2025.
While ratings are subjective and will change, the latest Gritstone Bio (GRTS) rating was a reiterated with a price target of $5.00 to $5.00. The current price Gritstone Bio (GRTS) is trading at is $0.67, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.